Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

Nature Medicine

Volumn 11, Issue 6, 2005, Pages 630-637

  Castor, Anders ^a,b   Nilsson, Lars ^a,b   Åstrand Grundström, Ingbritt ^a   Buitenhuis, Miranda ^c   Ramirez, Carole ^a   Anderson, Kristina ^a   Strömbeck, Bodil ^b   Garwicz, Stanislaw ^b   Békássy, Albert N ^b   Schmiegelow, Kjeld ^d   Lausen, Birgitte ^d   Hokland, Peter ^e   Lehmann, Sören ^f   Juliusson, Gunnar ^b   Johansson, Bertil ^b   Jacobsen, Sten Eirik W ^a,b  

^a Lund Stem Cell Center   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Rigshospitalet   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFORMATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ADP-RIBOSYL CYCLASE; ADULT; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD34; ANTIGENS, CD38; CHILD; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; FLOW CYTOMETRY; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MEMBRANE GLYCOPROTEINS; MUTATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANSLOCATION, GENETIC;

EID: 20944434753     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1253     Document Type: Article

References (49)

1. Bonnet, D. & Dick, J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737 (1997).
2. Reya, T., Morrison, S.J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111 (2001).
3. AI-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. From the Cover: Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003).
4. Fialkow, P.J., Denman, A.M., Jacobson, R.J., & Lowenthal, M.N. Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J. Clin. Invest. 62, 815-823 (1978).
5. Takahashi, N., Miura, I., Saitoh, K. & Miura, A.B. Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence- activated cell sorting and fluorescence in situ hybridization. Blood 92, 4758-4763 (1998).
6. Nilsson, L, et al. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 96, 2012-2021 (2000).
7. Chaudhary, P.M. & Roninson, I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66, 85-94 (1991).
8. Costello, R.T. et al. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 60, 4403-4411 (2000).
9. Zhou, S. et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028-1034 (2001).
10. Calvi, L.M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846 (2003).
11. Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841 (2003).
12. Tough, D.F. & Sprent, J. Lifespan of lymphocytes. Immunol. Res. 14, 1-12 (1995).
13. Larochelle, A., et al. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2, 1329-1337 (1996).
14. Quijano, C.A. et al. Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia. Leukemia 11. 1508-1515 (1997).
15. Cobaleda, C. et al. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood 95, 1007-1013 (2000).
16. George, A.A. et al. Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia. Stood 97, 3925-3930 (2001).
17. Cox, C.V. et al. Characterisation of acute lymphoblastic leukaemia progenitor cells. Blood 104, 2919-2925 (2004).
18. Pui, C.H., Relling, M.V., Campana, D. & Evans, W.E. Childhood acute lymphoblastic leukemia. Rev. Clin. Exp. Hematol. 6, 161-180 (2002).
19. Mori, H. et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl Acad. Sci. USA 99, 8242-8247 (2002).
20. Zelent, A., Greaves, M. & Enver, T. Role of the TEL-AMLl fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene 23, 4275-4283 (2004).
21. Maloney, K. et al. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification. Leukemia 13, 1708-1712 (1999).
22. Hotfilder, M. et al. Immature CD34+CD19- progenitor/stem cells in TEL/AML1-positive acute lymphoblastic leukemia are genetically and functionally normal. Blood 100, 640-646 (2002).
23. Faderl, S., Garcia-Manero, G., Thomas, D.A. & Kantarjian, H.M. Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives. Rev. Clin. Exp. Hematol. 6, 142-160 (2002).
24. Kurzrock, R. et al. A novel c-abl protein product in Philadelphia- positive acute lymphoblastic leukaemia. Nature 325, 631-635 (1987).
25. Clarkson, B., Strife, A., Wisniewski, D., Lambek, C.L. & Liu, C. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia 17, 1211-1262 (2003).
26. Jackson, G.H. et al. Philadelphia positive acute leukaemia with minor breakpoint cluster rearrangement may be a stem cell disease. Br. J. Haematol. 81, 77-80 (1992).
27. Haferlach, T. et al. New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level. Br. J. Haematol. 99, 452-459 (1997).
28. Schenk, T.M. et al. Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia. Leukemia 12, 666-674 (1998).
29. Pajor, L. et al. The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement. Leukemia 14, 1122-1126 (2000).
30. Bhatia, M., Wang, J.C., Kapp, U., Bonnet, D. & Dick, J.E. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl Acad. Sci. USA 94, 5320-5325 (1997).
31. Cumano, A., Paige, C.J., Iscove, N.M. & Brady, G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 356, 612-615 (1992).
32. Hogge, D.E., Lansdorp, P.M., Reid, D., Gerhard, B. & Eaves, C.J. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 88, 3765-3773 (1996).
33. Rickert, R.C., Rajewsky, K. & Roes, J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376, 352-355 (1995).
34. Hope, K.J., Jin, L. & Dick, J.E. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat. Immunol. 5, 738-743 (2004).
35. Passegue, E., Jamieson, C.H.M., Ailles, L.E. & Weissman, I.L. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl Acad. Sci. USA 100, 11842-11849 (2003).
36. Jordan, C.T. et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14, 1777-1784 (2000).
37. Bhatia, M., Bonnet, D., Murdoch, B., Gan, O.I. & Dick, J. E. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat. Med. 4, 1038-1045 (1998).
38. Tajima, F., Deguchi, T., Laver, J.H., Zeng, H. & Ogawa, M. Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. Stood 97, 2618-2624 (2001).
39. Dorrell, C., Can, O.I., Pereira, D.S., Hawley, R.G. & Dick, J.E. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood 95, 102-110 (2000).
40. Zanjani, E.D., Almeida-Porada, G., Livingston, A.G., Zeng, H. & Ogawa, M. Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. Exp. Hematol. 31, 406-412 (2003).
41. Wiemels, J.L. et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354, 1499-1503 (1999).
42. Wiemels, J.L., Ford, A.M., Van Wering, E.R., Postma, A. & Greaves, M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Stood 94, 1057-1062 (1999).
43. Baumgarth, N & Roederer, M. A practical approach to multicolor flow cytometry for immunophenotyping. J. Immunol. Methods 243, 77-97 (2000).
44. Lock, R.B. et al. The nonobese diabetic/severe combined immunodeficient (NOD/ SCID) mouse model of childhood acute lymphoblastic leukemia reveals intrinsic differences in biologic characteristics at diagnosis and relapse. Blood 99, 4100-4108 (2002).
45. Petzer, A.L. et al. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia. Blood 88, 2162-2171 (1996).
46. Jamieson, C.H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351, 657-667 (2004).
47. Nilsson, L. et al. Involvement and functional impairment of the CD34+CD38-Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 100, 259-267 (2002).
48. Darzynkiewicz, Z., Bedner, E. & Traganos, F. Difficulties and pitfalls in analysis of apoptosis. Methods Cell Biol. 63, 527-546 (2001).
49. Dybedal, I., Bryder, D., Fossum, A., Rusten, L.S. & Jacobsen, S.E.W. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood 98, 1782-1791 (2001).